PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33174139-0 2021 Memantine, NMDA Receptor Antagonist, Attenuates ox-LDL-Induced Inflammation and Oxidative Stress via Activation of BDNF/TrkB Signaling Pathway in HUVECs. Memantine 0-9 brain derived neurotrophic factor Homo sapiens 115-119 29656414-3 2018 We investigated whether add-on memantine to regular valproic acid treatment ameliorated clinical symptoms, reduced alcohol use, and cytokine levels, and increased plasma brain-derived neurotrophic factor (BDNF) in BD-II patients with comorbid alcohol dependence. Memantine 31-40 brain derived neurotrophic factor Homo sapiens 170-203 30344474-0 2018 Corrigendum: Prenatal Deltamethrin Exposure-Induced Cognitive Impairment in Offspring Is Ameliorated by Memantine Through NMDAR/BDNF Signaling in Hippocampus. Memantine 104-113 brain derived neurotrophic factor Homo sapiens 128-132 29656414-3 2018 We investigated whether add-on memantine to regular valproic acid treatment ameliorated clinical symptoms, reduced alcohol use, and cytokine levels, and increased plasma brain-derived neurotrophic factor (BDNF) in BD-II patients with comorbid alcohol dependence. Memantine 31-40 brain derived neurotrophic factor Homo sapiens 205-209 29656414-9 2018 CONCLUSIONS: BD-II comorbid with alcohol dependence might benefit from add-on memantine treatment, which significantly reduced clinical severity, alcohol use, and plasma cytokine levels, and increased BDNF levels. Memantine 78-87 brain derived neurotrophic factor Homo sapiens 201-205 24103632-7 2014 To adjust within-subject dependence over repeated assessments, multiple linear regression with generalized estimating equation methods was used to analyze the effects of the BDNF Val66Met polymorphism on the clinical performance of memantine. Memantine 232-241 brain derived neurotrophic factor Homo sapiens 174-178 29695962-8 2018 Moreover, NMDAR inhibition by memantine also prevented Abeta-driven deleterious impact of BDNF loss of function on structural (spine density) and functional outcomes (synaptic potentiation). Memantine 30-39 brain derived neurotrophic factor Homo sapiens 90-94 26660109-6 2016 Treatment with memantine (1-10 muM) improved STZ-induced neurotrophic factor decline (BDNF, GDNF) along with IR dysfunction as evidenced by a significant increase in IR protein expression, phosphorylation of IRS-1, Akt, and GSK-3 alpha/beta in astrocytes. Memantine 15-24 brain derived neurotrophic factor Homo sapiens 86-90 30984874-12 2018 Galantamine and memantine via the alpha7nACh and NMDA receptors can counteract the effects of kynurenic acid and enhance MMN and BDNF. Memantine 16-25 brain derived neurotrophic factor Homo sapiens 129-133 24103632-10 2014 We conclude that the BDNF Val66Met polymorphism influenced responses to add-on memantine by decreasing depressive symptoms in patients with BP-II. Memantine 79-88 brain derived neurotrophic factor Homo sapiens 21-25 19521778-0 2009 An involvement of BDNF and PI3-K/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons. Memantine 69-78 brain derived neurotrophic factor Homo sapiens 18-22 19521778-7 2009 Furthermore, the ELISA studies showed increased cellular and released BDNF protein level after combined treatment with memantine and staurosporine. Memantine 119-128 brain derived neurotrophic factor Homo sapiens 70-74